Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01726491 · ClinicalTrials.gov registry record
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 46
- Enrollment target
NCT01726491: Completed study, sponsored by Mayo Clinic.
NCT01726491 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01726491 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The investigators are trying to understand the role of DNA (deoxyribonucleic acid) methylation in insulin resistance in skeletal muscle and blood tissues. DNA methylation is a normal chemical process in the body that modifies DNA. By studying this, the investigators hope to better understand the causes of insulin resistance.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-11-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01726491
The ClinicalTrials.gov registry entry for NCT01726491 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01726491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01726491 about?
NCT01726491 is a clinical study titled "Epigenetics and the Origin of Muscle Insulin Resistance in Humans". The investigators are trying to understand the role of DNA (deoxyribonucleic acid) methylation in insulin resistance in skeletal muscle and blood tissues. DNA methylation is a normal chemical process in the body that modifies DNA. By studying this, the investigators hope to better understand the cau...
What is the current status of trial NCT01726491?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2012-08. Estimated completion is 2016-11-21.
Who is sponsoring clinical trial NCT01726491?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.